8-K - Alzamend Neuro, Inc. | StockGist

Current Report Details

Event Type

Charter Amendment

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.03

Amendments to Articles of Incorporation; Change in Fiscal Year. On October 14, 2025, Alzamend Neuro , Inc., a Delaware corporation (the “ Company ”), filed Cert

Charter Amendment

9.01

Financial Statements And Exhibits (d) Exhibits: Exhibit No. Description 3.1 Certificate of Elimination of the Series B convertible preferred stock, filed with t

Exhibits Only

Exhibits (3)

3.1

EXHIBIT 3.1

3.2

EXHIBIT 3.2

8-K

Exhibit